1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease : a dose escalation, open-label, phase 1/2 trial
- Contribution to journal › Article
- 2008
-
Mark
mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis
Trager, Catarina ; Vernby, Asa ; Kullman, Anita ; Øra, Ingrid LU
; Kogner, Per
and Kagedal, Bertil
(2008)
In International Journal of Cancer
123(12).
p.2849-2855
- Contribution to journal › Article